The Companion Animal Health Market Size accounted for USD 21.3 Billion in 2022 and is estimated to achieve a market size of USD 52.7 Billion by 2032 growing at a CAGR of 9.6% from 2024 to 2032.
Companion Animal Health Market Highlights
- Global companion animal health market revenue is poised to garner USD 52.7 billion by 2032 with a CAGR of 9.6% from 2024 to 2032
- North America companion animal health market value occupied around USD 7.9 billion in 2022
- Asia-Pacific companion animal health market growth will record a CAGR of more than 10.5% from 2024 to 2032
- Among product, the pharmaceuticals sub-segment generated more than USD 9.4 billion revenue in 2022
- Based on distribution channel, the hospital pharmacies sub-segment generated around 48% market share in 2022
- The dogs sub-segment in terms of animal type produced over USD 8.7 billion in revenue in 2022
- For the end-use category, clinics and veterinary hospitals accounted for approximately 81% market share in 2022
- Expansion into emerging markets with a growing middle class and increasing pet ownership is a popular companion animal health market trend that fuels the industry demand
Companion animals, such as dogs and cats, give important companionship while also acting as faithful guards of homes and businesses. These animals provide emotional support and camaraderie, which improves the lives of their human owners. However, intimate connection between companion animals and people might pose health hazards since some illnesses can be spread via close contact or the eating of animal products. Zoonotic illnesses, which may spread from animals to people, include rabies, salmonellosis, and toxoplasmosis. This rising worry has raised awareness about the importance of good pet ownership, which includes regular veterinarian care, vaccinations, and cleanliness measures.
Global Companion Animal Health Market Dynamics
Market Drivers
- Increasing companion animal ownership
- Growing prevalence of zoonotic diseases
- Rising favorable government initiatives
- Advances in veterinary technology and treatments
Market Restraints
- High cost associated with pet care
- Growing number of counterfeit drugs
- Limited access to veterinary services in rural areas
Market Opportunities
- Rising awareness towards animal health
- Surging investments in the pharma sector
- Growing demand for pet insurance and wellness plans
Companion Animal Health Market Report Coverage
| Market |
Companion Animal Health Market
|
| Companion Animal Health Market Size 2022 |
USD 21.3 Billion |
| Companion Animal Health Market Forecast 2032 |
USD 52.7 Billion
|
| Companion Animal Health Market CAGR During 2024 - 2032 |
9.6% |
| Companion Animal Health Market Analysis Period |
2020 - 2032 |
Companion Animal Health Market Base Year
|
2022 |
| Companion Animal Health Market Forecast Data |
2024 - 2032 |
| Segments Covered |
By Animal Type, By Product, By Distribution Channel, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Agrolabo S.p.A., Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck& Co., Nutreco N.V. Inc., Norbrook, Vetoquinol S.A., Virbac, and Zoetis.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Companion Animal Health Market Insights
Humanizing pets has had a significant influence on consumer purchase decisions and trends in the companion animal sector. This shift in view has resulted in a greater emphasis on pet health and well-being, as more people see their dogs as family members. This trend is helping to boost the companion animal health market by encouraging pet owners to invest in high-quality veterinarian care, pet insurance, and other health-related products and services for their dogs. Attributing human features and feelings to dogs has become more common throughout time, raising concerns about their health and safety. Pet owners are increasingly prioritizing preventative care and wellbeing for their animals, just as they would for their human family members. The American Veterinary Medical Association's survey found that expenditure on pet health and veterinary care has increased in recent years. This shows an increasing devotion to pet care and emphasizes the human-animal link.
The global increase in pet ownership, driven by changing lifestyles and rising disposable money, is likely to continue throughout the projection period. Furthermore, the growing demand for pet healthcare insurance in the United States contributes to this shift in consumer behavior by providing financial security and access to high-quality treatment for companion animals. Other factors driving the growth of the companion animal health market include the widespread availability of online shopping and home delivery services for pet items, which provide convenience to pet owners. Advanced technology in animal healthcare, such as telemedicine and new therapies, is also helping to fulfill pet owners' changing requirements. Furthermore, measures by the government and animal welfare organizations to encourage responsible pet ownership and animal health help to drive market growth.
Companion Animal Health Market Segmentation
The worldwide market for companion animal health is split based on animal type, product, distribution channel, end-use, and geography.
Companion Animal Health By Animal Types
- Dogs
- Cats
- Equine
- Poultry
- Sheep & Goats
According to our companion animal health industry analysis, the dogs sub-segment accounted for more than 40% of the market in 2021 and is expected to maintain this trend in the coming years. The global affection for dogs, as well as the increasing adoption of dogs for security purposes, are the two major factors supporting the dog market share. Furthermore, rapidly increasing urbanization, raising awareness of pet health insurance, and the growing importance of animal health are all likely to support the industry's dog segment.
Companion Animal Health Products
- Diagnostics
- Vaccines
- Pharmaceuticals
- Feed Additives
- Others
According to our companion animal health market forecast, pharmaceuticals are expected to hold significant market share from 2024 to 2032. On the other hand, pharmaceuticals sub-segment is likely to attain significant growth rate during the companion animal health market forecast period. The increasing number of zoonotic diseases occurring in pets and the growth in research & development activities to diagnose these diseases will spur the diagnostics sub-segment.
Companion Animal Health Distribution Channels
- E-commerce
- Retail
- Hospital Pharmacies
According to distribution channel, hospital pharmacies held the largest market share in 2022 and are expected to continue to do so in the companion animal health industry forecast period. The hospital pharmacies sub-segment is being driven by rising ease of access, a higher volume of prescriptions filled by these medical outlets, and an increase in demand for animal healthcare products. Furthermore, the increasing popularity of e-commerce will allow the market to expand even further in the coming years.
Companion Animal Health End-Uses
- Clinics and Veterinary Hospitals
- Point-of-Care Testing/In-house Testing
- Others
The veterinary hospitals and clinics sub-segment dominates the end-use market, owing to the high volume of patients served. These businesses provide a wide range of services, including general health checkups, surgeries, and immunisations, to meet the different needs of companion animals. Clients are drawn to veterinary hospitals and clinics because of the comprehensive care they give, as well as their capacity to execute modern diagnostic and therapeutic techniques. Furthermore, these institutions frequently include specialised technology and skilled staff, allowing them to manage difficult situations effectively. As a result, the industry is expanding, fueled by the need for high-quality care and the rising tendency of treating dogs like family members.
Companion Animal Health Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Companion Animal Health Market Regional Analysis
In terms of companion animal health market analysis, North America accounted for a considerable percentage of the worldwide, owing to the presence of important companies pursuing comprehensive growth strategies. These prominent market players have made significant investments in research and development (R&D), resulting in the launch of novel goods and services designed to fulfill the different demands of companion animals. This dedication to ongoing development and technical advancement has helped North America maintain its industry-leading position.
Another important aspect contributing to North America's supremacy is the increased frequency of chronic animal illnesses, which requires better medical care and treatment alternatives. The increased prevalence of chronic diseases in pets has encouraged veterinarians and healthcare professionals to implement cutting-edge technology such as diagnostics, therapies, and preventative measures. As a result, there is a greater emphasis on modernizing companion animal care and improving general well-being.
Companion Animal Health Market Players
Some of the top companion animal health companies offered in our report includes Agrolabo S.p.A., Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck& Co., Nutreco N.V. Inc., Norbrook, Vetoquinol S.A., Virbac, and Zoetis.
CHAPTER 1. Industry Overview of Companion Animal Health Market
1.1. Definition and Scope
1.1.1. Definition of Companion Animal Health
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Companion Animal Health Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Companion Animal Health Market By Animal Type
1.2.3. Companion Animal Health Market By Product
1.2.4. Companion Animal Health Market By Distribution Channel
1.2.5. Companion Animal Health Market By End-Use
1.2.6. Companion Animal Health Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Companion Animal Health Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Companion Animal Health Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Companion Animal Health Market By Animal Type
5.1. Introduction
5.2. Companion Animal Health Revenue By Animal Type
5.2.1. Companion Animal Health Revenue (USD Billion) and Forecast, By Animal Type, 2020-2032
5.2.2. Dogs
5.2.2.1. Dogs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Cats
5.2.3.1. Cats Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Equine
5.2.4.1. Equine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Poultry
5.2.5.1. Poultry Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Sheep & Goats
5.2.6.1. Sheep & Goats Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Companion Animal Health Market By Product
6.1. Introduction
6.2. Companion Animal Health Revenue By Product
6.2.1. Companion Animal Health Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Diagnostics
6.2.2.1. Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Vaccines
6.2.3.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Pharmaceuticals
6.2.4.1. Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4.2. Prescription
6.2.4.2.1. Prescription Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4.3. OTC
6.2.4.3.1. OTC Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Feed Additives
6.2.5.1. Feed Additives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Companion Animal Health Market By Distribution Channel
7.1. Introduction
7.2. Companion Animal Health Revenue By Distribution Channel
7.2.1. Companion Animal Health Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
7.2.2. E-commerce
7.2.2.1. E-commerce Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Retail
7.2.3.1. Retail Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Hospital Pharmacies
7.2.4.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Companion Animal Health Market By End-Use
8.1. Introduction
8.2. Companion Animal Health Revenue By End-Use
8.2.1. Companion Animal Health Revenue (USD Billion) and Forecast, By End-Use, 2020-2032
8.2.2. Clinics and Veterinary Hospitals
8.2.2.1. Clinics and Veterinary Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Point-of-Care Testing/In-house Testing
8.2.3.1. Point-of-Care Testing/In-house Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Companion Animal Health Market By Country
9.1. North America Companion Animal Health Market Overview
9.2. U.S.
9.2.1. U.S. Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.S. Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
9.2.3. U.S. Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.2.4. U.S. Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.3. Canada
9.3.1. Canada Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Canada Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
9.3.3. Canada Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3.4. Canada Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Companion Animal Health Market By Country
10.1. Europe Companion Animal Health Market Overview
10.2. U.K.
10.2.1. U.K. Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. U.K. Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
10.2.3. U.K. Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.2.4. U.K. Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.3. Germany
10.3.1. Germany Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Germany Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
10.3.3. Germany Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3.4. Germany Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.4. France
10.4.1. France Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. France Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
10.4.3. France Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4.4. France Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.5. Spain
10.5.1. Spain Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Spain Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
10.5.3. Spain Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5.4. Spain Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. Rest of Europe Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
10.6.3. Rest of Europe Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6.4. Rest of Europe Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Companion Animal Health Market By Country
11.1. Asia Pacific Companion Animal Health Market Overview
11.2. China
11.2.1. China Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. China Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.2.3. China Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.2.4. China Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.3. Japan
11.3.1. Japan Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Japan Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.3.3. Japan Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3.4. Japan Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.4. India
11.4.1. India Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. India Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.4.3. India Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4.4. India Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.5. Australia
11.5.1. Australia Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.2. Australia Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.5.3. Australia Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5.4. Australia Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.6. South Korea
11.6.1. South Korea Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.2. South Korea Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.6.3. South Korea Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.6.4. South Korea Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.2. Rest of Asia-Pacific Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
11.7.3. Rest of Asia-Pacific Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.7.4. Rest of Asia-Pacific Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Companion Animal Health Market By Country
12.1. Latin America Companion Animal Health Market Overview
12.2. Brazil
12.2.1. Brazil Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. Brazil Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
12.2.3. Brazil Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.2.4. Brazil Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.3. Mexico
12.3.1. Mexico Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. Mexico Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
12.3.3. Mexico Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3.4. Mexico Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Latin America Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
12.4.3. Rest of Latin America Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4.4. Rest of Latin America Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Companion Animal Health Market By Country
13.1. Middle East & Africa Companion Animal Health Market Overview
13.2. GCC
13.2.1. GCC Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.2. GCC Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
13.2.3. GCC Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.2.4. GCC Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.3. South Africa
13.3.1. South Africa Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.2. South Africa Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
13.3.3. South Africa Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.3.4. South Africa Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Companion Animal Health Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.2. Rest of Middle East & Africa Companion Animal Health Revenue (USD Billion) and Forecast By Animal Type, 2020-2032
13.4.3. Rest of Middle East & Africa Companion Animal Health Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.4.4. Rest of Middle East & Africa Companion Animal Health Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Companion Animal Health Market
14.1. Companion Animal Health Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Companion Animal Health Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Agrolabo S.p.A.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Agrolabo S.p.A. 2022 Companion Animal Health Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Bayer AG
15.3. Boehringer Ingelheim International GmbH
15.4. Ceva
15.5. Elanco
15.6. IDEXX Laboratories, Inc.
15.7. Indian Immunologicals Ltd.
15.8. Merck& Co.
15.9. Nutreco N.V. Inc.
15.10. Norbrook
15.11. Vetoquinol S.A.
15.12. Virbac
15.13. Zoetis
